Literature DB >> 24322453

Cancer-associated myositis: a 35-year retrospective study of a monocentric cohort.

Rossella Neri1, Simone Barsotti, Barsotti Simone, Valentina Iacopetti, Giacomo Iacopetti, Pasquale Pepe, Anna d'Ascanio, Antonio Gaetano Tavoni, Marta Mosca, Stefano Bombardieri.   

Abstract

This study is aimed at retrospectively studying cancer-associated inflammatory myopathies (CAM) in a cohort of patients with inflammatory myopathies. CAM were diagnosed if the tumor was diagnosed 2 years before or after disease onset. One hundred and sixty-two patients were included, 27 (17 %) had CAM. A significant association was observed between CAM and dermatomyositis (DM), older age and dysphagia at disease onset. CAM have lower creatine kinase (CK) levels at onset and a low prevalence of autoantibodies. In conclusion, the association of male sex, older age, DM, dysphagia at onset, lower CK, and autoantibodies negativity carries a high suspicion of CAM.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24322453     DOI: 10.1007/s00296-013-2910-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  21 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

Review 2.  Jo-1 syndrome with associated poorly differentiated adenocarcinoma.

Authors:  J Watkins; R Farzaneh-Far; H Tahir; F Wykes; P R Studdy; H L C Beynon
Journal:  Rheumatology (Oxford)       Date:  2004-03       Impact factor: 7.580

3.  Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study.

Authors:  B Sigurgeirsson; B Lindelöf; O Edhag; E Allander
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

4.  High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis.

Authors:  C R Maoz; P Langevitz; A Livneh; Z Blumstein; M Sadeh; I Bank; H Gur; M Ehrenfeld
Journal:  Semin Arthritis Rheum       Date:  1998-04       Impact factor: 5.532

5.  Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study.

Authors:  Y J Chen; C Y Wu; J L Shen
Journal:  Br J Dermatol       Date:  2001-04       Impact factor: 9.302

6.  Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.

Authors:  C L Hill; Y Zhang; B Sigurgeirsson; E Pukkala; L Mellemkjaer; A Airio; S R Evans; D T Felson
Journal:  Lancet       Date:  2001-01-13       Impact factor: 79.321

7.  Cancer-associated myositis: clinical features and prognostic signs.

Authors:  Andrea Ponyi; Tamás Constantin; Miklós Garami; Csilla András; Béla Tállai; Andrea Váncsa; Lajos Gergely; Katalin Dankó
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

8.  The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis.

Authors:  Vidya Limaye; Colin Luke; Graeme Tucker; Catherine Hill; Susan Lester; Peter Blumbergs; Peter Roberts-Thomson
Journal:  Rheumatol Int       Date:  2012-07-26       Impact factor: 2.631

9.  Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome.

Authors:  Dominic Legault; John McDermott; Ana Maria Crous-Tsanaclis; Gilles Boire
Journal:  J Rheumatol       Date:  2008-01       Impact factor: 4.666

10.  Elevated cancer incidence in patients with dermatomyositis: a population based study.

Authors:  A Airio; E Pukkala; H Isomäki
Journal:  J Rheumatol       Date:  1995-07       Impact factor: 4.666

View more
  7 in total

Review 1.  Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.

Authors:  Eleni Tiniakou; Andrew L Mammen
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

2.  Geographical Latitude Remains as an Important Factor for the Prevalence of Some Myositis Autoantibodies: A Systematic Review.

Authors:  Andrea Aguilar-Vazquez; Efrain Chavarria-Avila; Oscar Pizano-Martinez; Alejandra Ramos-Hernandez; Lilia Andrade-Ortega; Edy-David Rubio-Arellano; Monica Vazquez-Del Mercado
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

3.  Retrospective Analysis of Cancer-Associated Myositis Patients over the Past 3 Decades in a Hungarian Myositis Cohort.

Authors:  Csilla András; Levente Bodoki; Melinda Nagy-Vincze; Zoltán Griger; Emese Csiki; Katalin Dankó
Journal:  Pathol Oncol Res       Date:  2019-10-23       Impact factor: 3.201

Review 4.  Current Treatment for Myositis.

Authors:  Simone Barsotti; Ingrid E Lundberg
Journal:  Curr Treatm Opt Rheumatol       Date:  2018-09-15

Review 5.  Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected].

Authors:  Alain Meyer; Carlo Alberto Scirè; Rosaria Talarico; Tobias Alexander; Zahir Amoura; Tadej Avcin; Simone Barsotti; Lorenzo Beretta; Jelena Blagojevic; Gerd Burmester; Ilaria Cavazzana; Patrick Cherrin; Laura Damian; Andrea Doria; João Eurico Fonseca; Federica Furini; Ilaria Galetti; Frederic Houssiau; Thomas Krieg; Larosa Maddalena; David Launay; Raquel Campanilho-Marques; Thierry Martin; Marco Matucci-Cerinic; Pia Moinzadeh; Carlomaurizio Montecucco; Maria Francisca Moraes-Fontes; Luc Mouthon; Rossella Neri; Sabrina Paolino; Yves Piette; Simona Rednic; Farah Tamirou; Angela Tincani; Natasa Toplak; Stefano Bombardieri; Eric Hachulla; Ulf Mueller-Ladner; Matthias Schneider; Vanessa Smith; Ana Vieira; Maurizio Cutolo; Marta Mosca; Lorenzo Cavagna
Journal:  RMD Open       Date:  2019-02-26

6.  A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies.

Authors:  Alexander G S Oldroyd; Andrew B Allard; Jeffrey P Callen; Hector Chinoy; Lorinda Chung; David Fiorentino; Michael D George; Patrick Gordon; Kate Kolstad; Drew J B Kurtzman; Pedro M Machado; Neil J McHugh; Anna Postolova; Albert Selva-O'Callaghan; Jens Schmidt; Sarah Tansley; Ruth Ann Vleugels; Victoria P Werth; Rohit Aggarwal
Journal:  Rheumatology (Oxford)       Date:  2021-06-18       Impact factor: 7.580

Review 7.  Update on Malignancy in Myositis-Well-Established Association with Unmet Needs.

Authors:  Aleksandra H Opinc; Joanna S Makowska
Journal:  Biomolecules       Date:  2022-01-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.